Clinical Trial Update: Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on mesenchymal stem cell transplantation for acute cerebral infarction (Phase 1/Phase 2) with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Infarction
• Cerebral Infarction
• Stroke
• Stroke Ischemic

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Shanghai East Hospital | Conditions: Infarction, Middle Cerebral Artery, Infarction, Anterior Cerebral Artery | Phase 1, Phase 2 | Status: UNKNOWN